Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.42, read 2026-11-05
Ethical screen not yet scored
Price44.53
Fair value42.14
Ethical score50.0/100
Value readFairas of 6 Nov 2026
Our investment reviews on this name
2026-10-02Read Markup43.16+3.2% to today ✓Distribution gives way to Markup first Markup read since August
2026-09-03Read Distribution42.97+3.6% to today Markup gives way to Distribution first Distribution read since August
2026-08-03Read Markup42.97+3.6% to today ✓Distribution gives way to Markup
2026-07-02Read Distribution42.97+3.6% to today First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
BP PLC holds its Distribution at $44.53. The statistical read favours the buyers, held for 9 days.
As held on the ledger · 2026-11-06
Phase
Distribution · caution
Quantitative state
The statistical read favours the buyers, held for 9 days
Price at the screen
$44.53
Valuation
35.52 trailing · 10.49 forward price to earnings
Values screen
Not scored· score 50.0
Beta
-0.22
The Workings
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Revenue purity
0.85%
Below 5%
Only 0.8% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
The Read, in Plain English
BP clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Conscience flag · Don’t Buy Into Occupation, Palestinian BDS National Committee
The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Documented on Don’t Buy Into Occupation / Palestinian BDS National Committee — category: Corporate Complicity Report / Annex 2 Company List. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 6 Nov 2026: it trades above our 42.14 fair value estimate, weak competitive moat, 11.60% revenue growth.
Fair value range in , drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. The price runs 5.7% above the base estimate.
Third-party analyst targets: 17 covering, consensus Buy. The average target sits +11% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to United Kingdom and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
BP trades on NYSE (ADR) (the company is based in United Kingdom). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-01Markup$50.39+4.0%Entry 17
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 51%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (17 analysts) rates it buy, with a mean price target of $49.
2026-10-25Markup$48.44+0.0%Entry 16
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 51%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (17 analysts) rates it buy, with a mean price target of $49.
2026-10-18Markup$48.44+12.2%Entry 15
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 51%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (17 analysts) rates it buy, with a mean price target of $49.
2026-10-11Markup$43.16+0.0%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 51%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (17 analysts) rates it buy, with a mean price target of $49.
2026-10-02Markup · changed$43.16+0.4%Entry 13
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 51%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (17 analysts) rates it buy, with a mean price target of $49.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 51%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (17 analysts) rates it buy, with a mean price target of $49.
2026-08-04Markup$42.97+0.0%Entry 11
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 51%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (17 analysts) rates it buy, with a mean price target of $49. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-03Markup · changed$42.97+0.0%Entry 10
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 51%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (17 analysts) rates it buy, with a mean price target of $49. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-02Distribution$42.97+0.0%Entry 9
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 51%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (17 analysts) rates it buy, with a mean price target of $49. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-01Distribution$42.97+0.0%Entry 8
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 51%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (17 analysts) rates it buy, with a mean price target of $49. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
